Julien Sage

26.8k citations

150 papers · 14.2k indexed · 6 hit papers · h-index 64

Impact in

Oncology top 0.2%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
Cancer Research top 0.5%

Papers in

Oncology 93
- Cancer-related Molecular Pathways 43
- Lung Cancer Research Studies 39
Ophthalmology 16
- Ocular Oncology and Treatments 16

Co-authors: Deborah L. Burkhart Tyler Jacks Charles M. Rudin Élisabeth Brambilla Corinne Faivre‐Finn Abigail L. Miller Atul J. Butte Patrick Viatour
Journals: Cancer Research (9 papers)Genes & Development (7 papers)Nature (7 papers)Oncogene (5 papers)Cancer Discovery (5 papers)
Partner nations: United States France Germany

In The Last Decade

Julien Sage

145 papers receiving 14.1k citations

Hit Papers

6 papers align trajectories log scale

Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation 2023 · 75 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Cancer Discovery
2021 Nature Reviews Disease Primers
2019 Cancer Discovery
2019 Nature reviews. Cancer
2011 Science Translational Medicine
2008 Nature reviews. Cancer

Peers

Countries citing papers authored by Julien Sage

Since Specialization

Citations

This map shows the geographic impact of Julien Sage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Sage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Sage more than expected).

Fields of papers citing papers by Julien Sage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Sage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Sage. The network helps show where Julien Sage may publish in the future.

Co-authors

The 25 scholars most cited alongside Julien Sage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julien Sage Line = papers co-authored together Julien Sage links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genetically-engineered mouse models of small cell lung cancer: the next generation Oncogene ·Matthew G. Oser, David MacPherson, Trudy G. Oliver, Julien Sage, (unknown)	2024	18
2	A multiplexed in vivo approach to identify driver genes in small cell lung cancer Cell Reports ·Myung Chang Lee, Hongchen Cai, Christopher W. Murray, Chuan Li, Yan Ting Shue, Laura Andrejka, Andy He, Alessandra Holzem, Alexandros P. Drainas, Julie H. Ko, Garry L. Coles, Christina S. Kong, Shirley Zhu, Chunfang Zhu, Jason Wang, Matt van de Rijn, Dmitri A. Petrov, Monte M. Winslow, Julien Sage	2023	15
3	Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation Cancer Discovery ·Smruthy Sivakumar, Jay A. Moore, Meagan Montesion, Radwa Sharaf, Douglas I. Lin, Caterina I. Colón, Zoe Fleishmann, Ericka M. Ebot, Justin Y. Newberg, Jennifer M. Mills, Priti Hegde, Quintin Pan, Afshin Dowlati, Garrett M. Frampton, Julien Sage, Christine M. Lovly Hit paper breakdown →	2023	75
4	An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma Bioengineering & Translational Medicine ·Brianna J. McIntosh, Griffin G. Hartmann, Sean A. Yamada‐Hunter, Phillip Liu, Camille F. Williams, Julien Sage, Jennifer R. Cochran	2023	4
5	OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage Nature ·Xiaoli Wu, Xue‐Yan He, Jonathan J. Ipsaro, Yuhan Huang, Jonathan Preall, David Ng, Yan Ting Shue, Julien Sage, Mikala Egeblad, Leemor Joshua‐Tor, Christopher R. Vakoc	2022	48
6	A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs Nature Communications ·Yan Ting Shue, Alexandros P. Drainas, Nancy Yanzhe Li, Sarah M. Pearsall, Derrick Morgan, Nasa Sinnott-Armstrong, Susan Q. Hipkins, Garry L. Coles, Jing Lim, Anthony E. Oro, Kathryn Simpson, Caroline Dive, Julien Sage	2022	33
7	Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis Nature ·Roarke A. Kamber, Yoko Nishiga, Bhek Morton, Allison Banuelos, Amira Barkal, Felipe Vences‐Catalán, Mingxin Gu, Daniel Fernández, José A. Seoane, David Yao, Katherine Liu, Sijie Lin, Kaitlyn Spees, Christina Curtis, Livnat Jerby‐Arnon, Irving L. Weissman, Julien Sage, Michael C. Bassik	2021	118
8	RB depletion is required for the continuous growth of tumors initiated by loss of RB PLoS Genetics ·Alex Doan, Julia Arand, Diana Gong, Alexandros P. Drainas, Yan Ting Shue, Myung Chang Lee, Shuyuan Zhang, David M. Walter, Andrea C. Chaikovsky, David M. Feldser, Hannes Vogel, Lukas E. Dow, Jan M. Skotheim, Julien Sage	2021	5
9	The Long-Lost Ligase: CRL4 ^AMBRA1 Regulates the Stability of D-Type Cyclins DNA and Cell Biology ·Andrea C. Chaikovsky, Julien Sage, Michele Pagano, Daniele Simoneschi	2021	6
10	The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer Cancer Research ·Sandra Cristea, Garry L. Coles, Daniel Hornburg, Maya Gershkovitz, Julia Arand, Siqi Cao, Triparna Sen, Stuart C. Williamson, Jun W. Kim, Alexandros P. Drainas, Andrew He, Laurent Le Cam, Lauren A. Byers, M Snyder, Kévin Contrepois, Julien Sage	2020	52
11	RB1 Deletion in Retinoblastoma Protein Pathway-Disrupted Cells Results in DNA Damage and Cancer Progression Molecular and Cellular Biology ·Aren E. Marshall, Michael V. Roes, Daniel T. Passos, Megan C. DeWeerd, Andrea C. Chaikovsky, Julien Sage, Christopher J. Howlett, Frederick A. Dick	2019	30
12	Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer Cancer Discovery ·Triparna Sen, B. Leticia Rodriguez, Limo Chen, Carminia Maria Della Corte, Naoto Morikawa, Junya Fujimoto, Sandra Cristea, Thuyen Nguyen, Lixia Diao, Lerong Li, You-Hong Fan, Yongbin Yang, Jing Wang, Bonnie S. Glisson, Ignacio I. Wistuba, Julien Sage, John V. Heymach, Don L. Gibbons, Lauren A. Byers Hit paper breakdown →	2019	616
13	A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer Clinical Cancer Research ·Paul Ponath, Daniel L. Menezes, Chin Pan, Bing Chen, Miho Oyasu, Debbie Strachan, Heidi Leblanc, Huadong Sun, Xitao Wang, Vangipuram S. Rangan, Shrikant Deshpande, Sandra Cristea, (unknown), Julien Sage, Pina M. Cardarelli	2018	39
14	Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin Cancer Discovery ·Dian Yang, Sarah K. Denny, Peyton Greenside, Andrea C. Chaikovsky, Jennifer J. Brady, Youcef Ouadah, Jeffrey M. Granja, Nadine S. Jahchan, Jing Lim, Shirley Kwok, Christina S. Kong, Anna S. Berghoff, Anna Schmitt, Hans Christian Reinhardt, (unknown), Matthias Preusser, Anshul Kundaje, William J. Greenleaf, Julien Sage, Monte M. Winslow	2018	104
15	A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors Cancer Discovery ·Nadine S. Jahchan, Joel T. Dudley, Paweł K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton, Anne‐Flore Zmoos, Dedeepya Vaka, Kim Q.T. Tran, Margaret Zhou, Karolina Krasinska, Jonathan W. Riess, Joel W. Neal, Purvesh Khatri, (unknown), Atul J. Butte, Julien Sage	2013	275
16	Inactivating All Three Rb Family Pocket Proteins Is Insufficient to Initiate Cervical Cancer Cancer Research ·Myeong-Kyun Shin, Julien Sage, Paul F. Lambert	2012	30
17	Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma Cancer Research ·Bethany E. Schaffer, (unknown), Gloria Yiu, Jamie F. Conklin, Chenwei Lin, Deborah L. Burkhart, Anthony N. Karnezis, E. Alejandro Sweet‐Cordero, Julien Sage	2010	161
18	Tandem E2F Binding Sites in the Promoter of the p107 Cell Cycle Regulator Control p107 Expression and Its Cellular Functions PLoS Genetics ·Deborah L. Burkhart, Stacey E. Wirt, Anne‐Flore Zmoos, Michael S. Kareta, Julien Sage	2010	28
19	Methylation of the Retinoblastoma Tumor Suppressor by SMYD2 Journal of Biological Chemistry ·Louis Saddic, Lisandra West, Aaron Aslanian, John R. Yates, Seth M. Rubin, Or Gozani, Julien Sage	2010	179
20	The Related Retinoblastoma (pRb) and p130 Proteins Cooperate to Regulate Homeostasis in the Intestinal Epithelium Journal of Biological Chemistry ·Kevin M. Haigis, Julien Sage, Jon Glickman, Sarah A Shafer, Tyler Jacks	2005	61

About Julien Sage

Julien Sage is a scholar working on Oncology, Ophthalmology, Molecular Biology, Cancer Research and Epidemiology, having authored 150 papers that have together received 14.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (43 papers), Lung Cancer Research Studies (39 papers), Neuroendocrine Tumor Research Advances (26 papers), Epigenetics and DNA Methylation (22 papers), Ocular Oncology and Treatments (16 papers), Ubiquitin and proteasome pathways (13 papers), Cancer therapeutics and mechanisms (11 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Oncology (6.7k citations), Cancer Research (2.0k citations), Molecular Biology (8.9k citations), Aging (125 citations) and Ophthalmology (597 citations). Julien Sage has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Deborah L. Burkhart, Tyler Jacks, Charles M. Rudin, Élisabeth Brambilla, Corinne Faivre‐Finn, Abigail L. Miller, Atul J. Butte, Patrick Viatour, Sandra Cristea and Seth M. Rubin. Their work appears in journals such as Cancer Research, Genes & Development, Nature, Oncogene and Cancer Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact